Rosuvastatina, resistência à insulina, adiposidade, inflamação e esteatose hepática em camundongos alimentados com dieta hiperlipídica

Rosuvastatina, resistência à insulina, adiposidade, inflamação e esteatose hepática em camundongos alimentados com dieta hiperlipídica

Show other versions (1)

Conselho Nacional de Desenvolvimento Científico e Tecnológico === O estudo teve como objetivo avaliar os efeitos da rosuvastatina (ST) e darosiglitazona sobre a resistência à insulina (RI), morfologia do fígado e do tecido adiposo em camundongos alimentados com dieta hiperlipídica (HF). O tratamento...

Full description

Bibliographic Details
Main Author:	Júlio César Fraulob Aquino
Other Authors:	Carlos Alberto Mandarim-de-Lacerda
Format:	Others
Language:	Portuguese
Published:	Universidade do Estado do Rio de Janeiro 2011
Subjects:	Obesidade Tiazolidinediona Rosuvastatina NAFLD SREBP-1c Resistência à insulin Camundongo Esteatose - Teses Rosuvastatin Thizolidinediones Obesity Insulin resistance Mice MORFOLOGIA
Online Access:	http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=9101

Similar Items

Rosuvastatina, resistência à insulina, adiposidade, inflamação e esteatose hepática em camundongos alimentados com dieta hiperlipídica
by: Júlio César Fraulob Aquino
Published: (2011)

Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models
by: Youying Zhang, et al.
Published: (2017-06-01)

Human Sterol Regulatory Element-Binding Protein 1a Contributes Significantly to Hepatic Lipogenic Gene Expression
by: Andreas Bitter, et al.
Published: (2015-01-01)

New targets for NAFLDKey points
by: Lucia Parlati, et al.
Published: (2021-12-01)

Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
by: Chunyi Wang, et al.
Published: (2018-04-01)

Insights into the Hexose Liver Metabolism—Glucose versus Fructose
by: Bettina Geidl-Flueck, et al.
Published: (2017-09-01)

Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells
by: Ke Fang, et al.
Published: (2019-09-01)

BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver
by: Jing Tian, et al.
Published: (2018-06-01)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
by: Takayasu Ideta, et al.
Published: (2015-12-01)

Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress
by: Yan Peng, et al.
Published: (2020-10-01)

Transcriptional Regulation of Acyl-CoA:Glycerol-<i>sn</i>-3-Phosphate Acyltransferases
by: Ken Karasawa, et al.
Published: (2019-02-01)

Deletions of Fstl3 and/or Fst Isoforms 303 and 315 Results in Hepatic Steatosis
by: Ungerleider, Nathan A
Published: (2010)

Efeitos de diferentes doses de rosuvastatina no metabolismo lipídico e dos carboidratos, morfometria do tecido adiposo e remodelamento cardíaco de camundongos C57BL/6 alimentados com dieta hiperlipídica
by: Vinícius Novaes Rocha
Published: (2013)

Efeitos de diferentes doses de rosuvastatina no metabolismo lipídico e dos carboidratos, morfometria do tecido adiposo e remodelamento cardíaco de camundongos C57BL/6 alimentados com dieta hiperlipídica
by: Vinícius Novaes Rocha
Published: (2013)

The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an <em>in vitro</em> model of benign steatosis
by: Andrea Ferrigno, et al.
Published: (2020-11-01)

SREBP-1c Gene Silencing can Decrease Lipid Deposits in Bovine Hepatocytes Cultured in Vitro
by: Qinghua Deng, et al.
Published: (2014-05-01)

Expression and clinical significance of LXRα and SREBP-1c in placentas of preeclampsia
by: Jianhua Li, et al.
Published: (2016-01-01)

Novel roles of sterol regulatory element-binding protein-1 in liver
by: Jideonwo, Victoria N.
Published: (2016)

FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c
by: Liu Wang, et al.
Published: (2019-11-01)

Desempenho, características de carcaça e expressão de genes em tourinhos alimentados com lipídeos e monensina
by: Márcio Machado Ladeira, et al.
Published: (2014-09-01)

Rôle des facteurs de transcription SREBP-1 dans la fonction musculaire : implication des répresseurs transcriptionnels BHLHB2 et BHLHB3
by: Lecomte, Virginie
Published: (2009)

Enhanced Liver Regeneration After Partial Hepatectomy in Sterol Regulatory Element-Binding Protein (SREBP)-1c-Null Mice is Associated with Increased Hepatocellular Cholesterol Availability
by: Jun Peng, et al.
Published: (2018-05-01)

Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat
by: Vishal Singh, et al.
Published: (2015-01-01)

Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease
by: Nevin Oruc;, et al.
Published: (2009-04-01)

Carnosic acid alleviates hyperlipidemia and insulin resistance by promoting the degradation of SREBPs via the 26S proteasome
by: Zhishen Xie, et al.
Published: (2017-04-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Regulation of sterol regulatory element binding protein-1 in bovine mammary epithelial cells
by: Chen, Liang
Published: (2016)

The Effect of Kelussia odoratissima Mozaff Extract on SREBP-1C Gene Expression in Fatty Liver Rats and Healthy Rats
by: zahra haghshenas, et al.
Published: (2021-05-01)

New insights into the activation of sterol regulatory element-binding proteins by proteolytic processing
by: Inoue Jun, et al.
Published: (2013-08-01)

Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade
by: Jörg Kotzka, et al.
Published: (2000-01-01)

Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein
by: Simon M. Jackson, et al.
Published: (1998-04-01)

Serum sdLDL-C and cellular SREBP2-dependent cholesterol levels: Is there a challenge on targeting PCSK9?
by: Soltanmohammadi Elham, et al.
Published: (2016-01-01)

Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
by: Jian Li, et al.
Published: (2018-03-01)

Curcumin, quercetin and atorvastatin protected against the hepatic fibrosis by activating AMP-activated protein kinase
by: Razieh Kabirifar, et al.
Published: (2018-01-01)

Missense variant in insulin receptor (Y1355H) segregates in family with fatty liver disease
by: Fei Luo, et al.
Published: (2021-11-01)

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review
by: Panayiotis Kouis, et al.
Published: (2014-05-01)

Sulfated polysaccharide from Enteromorpha prolifera suppresses SREBP-1c and ACC expression to lower serum triglycerides in high-fat diet-induced hyperlipidaemic rats
by: Rendong Ren, et al.
Published: (2018-01-01)

Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer
by: Qianqian Sun, et al.
Published: (2020-08-01)

The Effect of Three Mediterranean Diets on Remnant Cholesterol and Non-Alcoholic Fatty Liver Disease: A Secondary Analysis
by: Angelo Campanella, et al.
Published: (2020-06-01)

Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases
by: Suryaprakash Raichur
Published: (2020-07-01)